6th July 2026 By H&T Presspart
Challenges of Sustained Release Drug Delivery Devices Webinar
H&T Presspart to Host Webinar on the Challenges of Sustained Release Drug Delivery Devices
H&T Presspart is pleased to announce its upcoming webinar, “Challenges of Sustained Release Drug Delivery Devices”, hosted in collaboration with PMI Live. The session will bring together industry expertise to explore the key scientific, technical and commercial challenges associated with the development of sustained-release drug delivery systems.
Sustained-release drug delivery technologies continue to play an increasingly important role in modern pharmaceutical development, enabling improved patient adherence, reduced dosing frequency and more controlled therapeutic delivery. However, the development of these systems presents a range of challenges across formulation design, device engineering, manufacturing scale-up and regulatory compliance.
This webinar will provide attendees with practical insights into the complexities of sustained-release drug delivery device development, highlighting strategies to support innovation while managing technical and commercial risk.
The session will be presented by Dr. Anselm Ebert, Business Development Director at H&T Presspart, and Robert Fesus, Vice President Sales and Marketing, at Plas-Tech Engineering, who will share their combined expertise in drug delivery systems, device development and commercialisation.
During the webinar, attendees will gain insights into:
- The key challenges associated with sustained-release drug delivery devices
- Considerations in formulation and device design
- Manufacturing and scale-up challenges in long-acting drug delivery systems
- Strategies to reduce development risk and improve time to market
- Emerging trends shaping the future of sustained-release technologies
The webinar is designed for pharmaceutical and biotechnology professionals involved in formulation development, drug delivery, device engineering and combination product development. It will provide valuable guidance for organisations seeking to advance the development of long-acting and sustained-release therapies.
As demand continues to grow for patient-centric treatment options, sustained-release technologies are becoming a critical focus area for innovation. This webinar offers an opportunity to hear directly from industry experts and gain practical perspectives on overcoming development challenges.
